Work

Phase 1b dose-expansion study of IMC-002, a anti-CD47 monoclonal antibody, in patients with advanced triple negative breast cancer (TNBC).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.2524

Authors: Ji Hyung Hong, Keun Seok Lee, Sung Hoon Sim, Kyung Hae Jung, Hee Kyung Ahn, Junghoon Shin, Jin Seok Ahn, Subin Lee, SeongYeon Kang, Sung Young Lee, Heung Tae Kim

Institutions: National Cancer Center, National Cancer Center Hospital, Asan Medical Center, University of Ulsan, Samsung Medical Center, Sungkyunkwan University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162484811

Cites:

Cited by:

Related to: